Certified by Founder
Lodge
Korio, Inc.
start up
United States
- Doylestown, PA
- 11/10/2023
- Unknown
- $6,800,000
Korio is the industry’s leading compliance-centric Randomization & Trial Supply Management (RTSM) platform. Reflecting decades of hands-on experience across thousands of trial designs, Korio enables once aspirational goals around feature reusability, process repeatability, system performance, and overall system quality by embedding the latest RTSM design intelligence into our solution. Our intuitive approach to RTSM setup and management through a regulatory lens ensures audit-readiness and a predictable GxP compliant outcome on every clinical trial.
- Industry Software Development
- Website https://www.korioclinical.com/
- LinkedIn https://www.linkedin.com/company/korio-inc/about/
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)